Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
Conditions: Stem Cell Transplantation Interventions: Device: Cycle ergometer; Device: Strength Training - elastic band and shin guards; Device: Cycle ergometer, elastic band and shin guards Sponsors: Federal University of Health Science of Porto Alegre Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Dermogenesis With Mesenchymal Stem Cells
Conditions: Dermal Regeneration Interventions: Procedure: Autologous Mesenchymal stem cell injection Sponsors: King Edward Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Autologous ADMSC Transplantation in Patients With POI
Conditions: Premature Ovarian Failure Interventions: Biological: stem cell therapy Sponsors: Mongolian National University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
Conditions: Myeloid Malignancy; Acute Myeloid Leukemia Interventions: Drug: Venetoclax; Drug: Decitabine Sponsors: Benjamin Tomlinson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
Conditions: Acute Lymphoblastic Leukemia Interventions: Drug: Blinatumomab Sponsors: Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
Conditions: Hematopoietic Malignancy; Relapse/Recurrence; Hematopoietic Stem Cell Transplantation Interventions: Procedure: Umbilical Cord Blood Transplantation Sponsors: The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Umbilical Cord Mesenchymal Stem Cells for the Repair of Large Area Burn Wounds
Conditions: Large Area Burns Interventions: Procedure: Stem cell preparation combined with Reticular skin; Procedure: Stem cell preparation combined with MEEK skin; Procedure: Stem cell preparation combined with split-thickness skin; Procedure: autologous skin grafting Sponsors: ShiCang Yu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT
Conditions: Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation Interventions: Behavioral: yoga or gentle massage plus standard treatment for HSCT Sponsors: Hospital Israelita Albert Einstein Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Conditions: Glioblastoma Interventions: Diagnostic Test: 18F-GE-180 PET; Diagnostic Test: Advanced MRI; Other: Collection of hematopoietic stem cells; Other: Blood withdrawal; Other: Collection of Cancer Stem Cells Sponsors: Istituto Clinico Humanitas; Mediolanum Cardio Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Study of Human Bone Marrow Mesenchymal Stem Cells in aPAP
Conditions: Autoimmune Pulmonary Alveolar Proteinosis Interventions: Drug: human Bone Marrow Mesenchymal Stem Cell (hBMMSC) Sponsors: Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.; The First Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Iberdomide; Drug: Daratumumab/rHuPH20 Co-formulation Sponsors: Barbara Ann Karmanos Cancer Institute; Bristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research Consortium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
Conditions: Thrombotic Microangiopathies; Hematopoietic Stem Cell Transplantation Sponsors: Institute of Hematology& Blood Diseases Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Qualitative Study on Factors Impeding Physical Activity During the Post-discharge Period After Hematopoietic Stem Cell Transplantation in Children
Conditions: Physical Activities Interventions: Other: interview Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
A Prospective Approach for the Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health Clinical Center (CC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health Clinical Center (CC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
